ZYTIGA®▼ 250mg Tablets PRESCRIBING INFORMATION ACTIVE INGREDIENT(S): Abiraterone acetate Please refer to Summary of Product Characteristics (SmPC) before prescribing. INDICATION(S): Taken with prednisone or prednisolone for the treatment of metastatic castration resistant prostate cancer in adult men whose disease has progressed on or after a docetaxel- based chemotherapy regimen.
Advantag of ingestion administration way is its easiness even when applied at home. But with their help necessary treatment concentration in blood cannot be always quickly achieve doxycycline online transaction is carried out on anonymity and mutual profit principles, and in addition customers will be positively surprised with quality and speed of service.
In what quantities are lithium and lithium ion batteries generally shipped? Lithium
and lithium ion batteries are shipped in large and small quantities. For example, a single
package may contain as few as five batteries, a pallet may contain more than 1,000
batteries, or they may be packed with or contained in equipment.
Why do some packages of lithium and lithium ion batteries now contain a
“Caution” marking? Manufacturers of lithium and lithium ion batteries began
implementing a new voluntary air transportation communications program (VATCP) in
2001 as an added step in assuring air transportation safety of products that are currently
excepted from dangerous goods/hazardous materials regulations. By early 2001,
packages originating from program participants and shipped by air that contain more than
small quantities of excepted lithium or lithium ion cells and batteries will carry a
distinctive marking. It will clearly identify the presence of these cells and batteries. The
program participants also will provide additional documentation or notification on
shipping papers that these cells and batteries are being shipped and use upgraded
packaging. Packages containing very limited quantities of cells and batteries will not
carry the cautionary marking.
Must consumer-sized lithium or lithium ion batteries be shipped as regulated
dangerous goods/hazardous materials? No. Small, consumer-type lithium and lithium
ion batteries are provided an exception from dangerous goods/hazardous materials
regulations. For example, Special Provision 188 of the UN Recommendations on the
Transport of Dangerous Goods Model Regulations, Special Provision A45 of the ICAO
Technical Instructions for the Safe Transport of Dangerous Goods by Air, and Section
173.185 of the U.S. Hazardous Materials Regulations provide exceptions to the
regulations. Thus, packages containing small, consumer-type lithium and lithium ion
batteries DO NOT require the same markings, labels, and shipping papers as dangerous
Will all lithium and lithium ion battery manufacturers around the world participate
in the VATCP? Participants in the program manufacture the vast majority of lithium
and lithium ion batteries used in the world today. Starting on or about January 1, 2003,
however, the UN Recommendations on the Transport of Dangerous Goods Model
Regulations, and many other transportation regulations, will contain requirements similar
to the provisions in the VATCP. Thus, modified packaging, additional documentation,
and markings will be required for packages containing over a certain number of cells and
batteries. THESE CELLS AND BATTERIES, HOWEVER, WILL STILL BE
PROVIDED AN EXCEPTION FROM UN DANGEROUS GOODS/HAZARDOUS
What is the difference between lithium and lithium ion batteries? The biggest
differences are that lithium batteries contain lithium metal and are not rechargeable.
Lithium ion batteries, however, do not contain lithium metal and can be recharged.
What are some of the typical uses for lithium and lithium ion batteries? The small
lithium and lithium ion batteries that are provided an exception to dangerous
goods/hazardous materials regulations are used primarily in consumer applications.
Small lithium batteries are often used in cameras and watches. Lithium ion batteries are
commonly found in cellular phones and laptop computers.
Press Office ERA-EDTA Congress 2010 | albersconcept | Jakobstrasse 38 | 99423 Weimar | Germany THE EFFECT OF DUAL BLOCKADE OF RENIN ANGIOTENSIN SYSTEM (RAS) ON PROGRESSION OF TYPE 2 DIABETIC NEPHROPATHY José Luño, Head of the Department of Nephrology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. RAS blocking has been shown to reduce proteinuria and the rate of decli